← All organizations

Pionyr Immunotherapeutics Inc.

For profitWebsite ↗

Also known as: Pionyr Immunotherapeutics Inc. | Pionyr Immunotherapuetics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Last known activity

Nov 10, 2020

Acquired by Ikena Oncology on Aug 7, 2023

Timeline

2010s

Jun 1, 2015
Pionyr Immunotherapeutics Inc.— Founded

2020s

Aug 7, 2023
Ikena Oncology— Acquired By

Drugs by trial phase (3 distinct, 2 trials)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Neoplasms

Recent trials (4)

NCT04682431Lead sponsorPhase 1Nov 10, 2020
NCT04682431Study directorPhase 1Nov 10, 2020
NCT04691375Lead sponsorPhase 1Oct 29, 2020
NCT04691375Study directorPhase 1Oct 29, 2020

Details

Founded: San Francisco, CA, US Jun 1, 2015
Last known activity: Nov 10, 2020